Table 2.
Summary of selective medications within 6 months after transplant.
| All recurrence (n = 349) | Recur within 2 years (n = 213) | Recur after 2 years (n = 136) | P-value | |
|---|---|---|---|---|
| Immunosuppressants | ||||
| Tacrolimus (n, %) | 329 (94.3) | 198 (93.0) | 131 (96.3) | 0.279 |
| Cyclosporin (n, %) | 24 (6.9) | 16 (7.5) | 8 (5.9) | 0.712 |
| MMF (n, %) | 299 (85.7) | 178 (83.6) | 121 (89.0) | 0.212 |
| Sirolimus (n, %) | 49 (14.0) | 28 (13.1) | 21 (15.4) | 0.657 |
| Everolimus (n, %) | 65 (18.6) | 46 (21.6) | 19 (14.0) | 0.100 |
| Metformin (n, %) | 84 (24.1) | 51 (23.9) | 33 (24.3) | 1.000 |
| HBV medication | ||||
| Lamivudine (n, %) | 80 (22.9) | 38 (17.8) | 42 (30.9) | 0.007 |
| Entecavir (n, %) | 102 (29.2) | 69 (32.4) | 33 (24.3) | 0.132 |
| Tenofovir (n, %) | 12 (3.4) | 9 (4.2) | 3 (2.2) | 0.479 |
MMF, mycophenolate mofetil.